COVID-19 Funding Opportunities

University of Kentucky Internal Pilot Funding

• UK CURE - COVID-19 Pilot Program, Core 3- Social Sciences
• The University of Kentucky Center for Clinical and Translational Sciences - UK CURE COVID-19 Pilot Program
• UK CURE - COVID-19 Pilot Program, Core 2-Materials/Methods

American College of Emergency Physicians (ACEP) /Emergency Medicine Foundation (EMF)

• ACEP/EMF COVID-19 Research Grant - Deadline 06/05/20

Agency for Healthcare Research and Quality (AHRQ)

• Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement -  Clinical Trial Optional) - Deadline 05/29/20
• Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement -  Clinical Trial Optional)
• Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19 - Deadline 05/29/20
• Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

Biomedical Advanced Research and Development Authority (BARDA)

• Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) - Updated 03/09/20 - Deadlines: 06/31/2020 

Booz Allen Foundation

• Innovation Grant - COVID-19 - Deadline: 06/05/20

Department of Commerce / Economic Development Administration

• FY 2020 EDA Public Works and Economic Adjustment Assistance Programs including CARES Act Funding (PWEAA2020)

Department of Defense/MTEC

• DoD - MTEC-20-13-iMAS RPP "Interoperable Medical Automated Systems (iMAS) Technology and Gap Assessment" 6/18/2020
• Potential Topics of Upcoming Funding Opportunities in 2020
• Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response
• DoD- CDMRP - FY20 PRMRP Focus Areas for Emerging Viral Diseases and Respiratory Health
• FY20 Peer Reviewed Medical Research Program (PRMRP) Investigator-Initiated Research Award - Deadline 09/03/20
• FY20 Peer Reviewed Medical Research Program (PRMRP) Technology/ Therapeutic Development Award - Deadline 09/03/20
• FY20 Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award - Deadline 06/22/20

Emergent Ventures

• Fast Funding for COVID-19 Science - Applications are paused

Joint European Disruptive Initiative

• Billion Molecules against Covid-19

nanoString

• Neuroscience Grant Program: nCounter Glial Profiling Panel - Deadline: 05/29/20

National Institutes of Health

• Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) Deadline: August 18, 2020
• Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
• NINDS - Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
• NIAID - Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
• NHLBI Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials
• NLM - Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21)
• Common Fund - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
• NIAAA - Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA
• NLM - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)
• OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
• NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) (NOT-ES-20-014 is replaced by NOT-ES-20-017.)  
• NCCIH, NIA, NIAAA - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
• NIBIB - Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
• NIBIB - Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
• NIBIB - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
• NIDCD - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)
• NIDDK- Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK
• NIDDK - Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission
• NIMHD, NIA, NIMH - Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
• NIMH, NIA, NIAAA, NIMHD - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
• NIA, NIMH, NIAAA - Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• NCATS - Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)  
• NIDA -NIH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
• NHLBI -NIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)  
• NIAID, NIA - Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
• NIAID -NIH Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
• NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB, Common Fund, NCATS, NIAAA - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
• 2020 NIAID Omnibus Broad Agency Announcement
• NIEHS Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
• NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCD, NCI, NIDCR -NIH Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
• NIIAD - NIH Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)

National Science Foundation

• NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
• Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19

fizer, Inc. / Pfizer Global Medical Grants (GMG)

• Vaccine Preventable Diseases-COVID-19 - Deadline 06/17/2020

Robert Wood Johnson Foundation

• Emergency Response for the General Public Innovation Challenge
• Emergency Response for the Health Care System Innovation Challenge

Social Science Research Council

• Social Data Research and Dissertation Fellowships - Deadline 06/16/20
• Social Science & COVID-19 Research - Deadline:  06/01/20

Society for Academic Emergency Medicine Foundation (SAEM Foundation)

• SAEMF COVID-19 Research Grant - Deadline: 06/01/20

Spencer Foundation

• Research Grants on Education-  COVID-19-Related Special Grant Cycle - Deadlines: 05/18/20 and 06/08/20

Stanton Foundation

• Applying History to Clarify the COVID-19 Challenge - Weekly Contest - Ends 06/26/20

United Kingdom Government

• Medical Robotics for Contagious Diseases Challenge 2020 - Deadline 09/30/2020

United Nations Development Programme Centre for Technology, Innovation, and Sustainable Development -

• COVID-19 Detect and Protect Challenge

USDA/National Institute of Food and Agriculture

• USDA/NIFA - Rural Health and Safety Education (RHSE) Competitive Grants Program (USDA-NIFA-RHSE-007412)  Limited Submission Internal Deadline 06/09/20
• USDA/NIFA - AFRI Supplement: Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems (USDA-NIFA-AFRI-007052) - Deadline: 06/04/20